Hitachi selects Agilent Technologies' microarrays for pharmaceutical research
"We are pleased that Hitachi has selected Agilent for the supply of microarrays for its contract gene expression research in Japan," said Chris van Ingen, senior vice president of Agilent's Life Sciences and Chemical Analysis business. "We look forward to enabling Hitachi to generate gene expression information that will be used to identify causes of human diseases and the cures for those diseases."
Hitachi will use Agilent's catalog human, mouse and rat microarrays as well as custom designed microarrays. Until now, Hitachi has been using in-house developed microarrays for its research purposes. With the new service, Hitachi intends to attract those researchers who wish to do a wide range of research using a large number of gene and drug candidates.
Topics
Organizations
Other news from the department research and development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.